• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Can TMS Turn on the Switch?

Can TMS Turn on the Switch?

June 1, 2022
Edmund S. Higgins, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Edmund S. Higgins, MD. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

REVIEW OF: Miuli A et al, World J Psychiatry 2021;11(8):477–490

STUDY TYPE: Literature review and meta-analysis

Some treatments for depression, particularly antidepressants, present risk of manic reactions, but whether this risk exists with transcranial magnetic stimulation (TMS) is less clear.

A group in Italy searched the world’s literature for studies using TMS for mood disorders. They sought studies that were double blind or single blind and published in English to find reports of manic and hypomanic switching.

The authors found 25 studies (21 double blind and four single blind) with a total of 576 subjects in active treatment and 487 receiving sham treatment. The studies used a variety of TMS protocols, but the most common was administered over the left dorsolateral prefrontal cortex for two weeks at 10 Hz with 2000–3000 pulses per session. Only eight studies reported on adverse effects like manic switching. Of those, four reported manic or hypomanic switches—three in active treatment and one in sham. Although there was a trend toward switches, the difference was not statistically significant, leading the authors to conclude that TMS does not seem to increase the risk of these reactions.

The parameters of TMS can be opaque to those of us who are not fluent in electricity, so we sought out Mark S. George, MD, one of the founding fathers of TMS (George MS et al, Neuroreport 1995;6(14):1853–1856) and editor-in-chief of the journal Brain Stimulation. Dr. George was hesitant to embrace the authors’ conclusion from this analysis.

He noted that the usual length of treatment is four to six weeks, so the majority of the studies reviewed here were underdosed at only two weeks. Furthermore, many of the studies used a gentler form of TMS with low-intensity pulses. More recent TMS protocols have raised the frequency of the magnetic pulse to produce faster results, a change that—in theory—could also raise the risk of mania.

CARLAT TAKE

This study provides some reassurance that TMS does not cause manic switching. However, many of the studies were underdosed, and few systematically looked for side effects. For all intents and purposes, this analysis does not answer the question.

General Psychiatry
KEYWORDS depression tms transcranial magnetic stimulation treatment-resistant-depression
Edmund S. Higgins, MD.

A Review of Sexual Citizens

More from this author
www.thecarlatreport.com
Issue Date: June 1, 2022
SUBSCRIBE NOW
Table Of Contents
Quetiapine Reconsidered
Psychosis During Depression
Can TMS Turn on the Switch?
Uncommon Tips: Which Is Better—Citalopram or Escitalopram?
Benzodiazepines: A Reevaluation of Their Benefits and Dangers
How Essential Is Antidepressant Continuation?
Hypothyroidism and Depression: Just How Related Are They?
Topiramate Improves Weight in Schizophrenia in South Asians
CME Post-Test - Psychotic Depression, TCPR, June/July 2022
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.